Published in Clinical Oncology Week, August 18th, 2003
"From January 1999 to November 2000, a total of 24 esophageal cancer patients (17 untreated and seven recurrent cases) were treated with radiation therapy (60-70 Gy) combined with cis-diammine-glycolatoplatinum (Nedaplatin) (80-120 mg/body) and 5-fluorouracil (5-FU) (500-1,000 mg/body/24 h, continuous infusion for 5 days)," researchers in Japan report.
"Grade III leukocytopenia was observed in six (25%) of the patients. Grade III and IV thrombocytopenia was observed in one patient each," wrote K. Nemoto and colleagues, Tohoku University, School of Medicine.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week